Terms: = Liver cancer AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L AND Treatment
64 results:
1. Mitochondrial-Targeted CS@ket/P780 Nanoplatform for Site-Specific Delivery and High-Efficiency cancer Immunotherapy in Hepatocellular Carcinoma.
Liu S; Tian H; Ming H; Zhang T; Gao Y; Liu R; Chen L; Yang C; Nice EC; Huang C; Bao J; Gao W; Shi Z
Adv Sci (Weinh); 2024 Apr; 11(14):e2308027. PubMed ID: 38308137
[TBL] [Abstract] [Full Text] [Related]
2. Evolving landscape of treatments targeting the microenvironment of liver metastases in non-small cell lung cancer.
Zhu L; Yu X; Tang X; Hu C; Wu L; Liu Y; Zhou Q
Chin Med J (Engl); 2024 May; 137(9):1019-1032. PubMed ID: 38251678
[TBL] [Abstract] [Full Text] [Related]
3. Progress of immune checkpoint inhibitors therapy for non-small cell lung cancer with liver metastases.
Qu FJ; Zhou Y; Wu S
Br J Cancer; 2024 Feb; 130(2):165-175. PubMed ID: 37945751
[TBL] [Abstract] [Full Text] [Related]
4. Intrathyroid thymic carcinoma: A clinicopathological analysis of 22 cases.
Gao Y; Pan Y; Luo Y; Cheng R; Zhai Q
Ann Diagn Pathol; 2023 Dec; 67():152221. PubMed ID: 37925863
[TBL] [Abstract] [Full Text] [Related]
5. Advanced renal pelvis carcinoma patient with an ERBB2 insertion mutation: a case report.
Shang P; Lou C; Yin L; Tao C; Dong Y; Yang G; Yuan Z
J Int Med Res; 2023 Nov; 51(11):3000605231204502. PubMed ID: 37917812
[TBL] [Abstract] [Full Text] [Related]
6. Unlocking the Potential: Novel NSAIDs Hybrids Unleash Chemopreventive Power toward liver cancer Cells through Nrf2, NF-κB, and MAPK Signaling Pathways.
Narożna M; Krajka-Kuźniak V; Bednarczyk-Cwynar B; Baer-Dubowska W
Molecules; 2023 Jul; 28(15):. PubMed ID: 37570726
[TBL] [Abstract] [Full Text] [Related]
7. Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST.
de Mestier L; Resche-Rigon M; Dromain C; Lamarca A; La Salvia A; de Baker L; Fehrenbach U; Pusceddu S; Colao A; Borbath I; de Haas R; Rinzivillo M; Zerbi A; Funicelli L; de Herder WW; Selberherr A; Wagner AD; Manoharan P; De Cima A; Lybaert W; Jann H; Prinzi N; Faggiano A; Annet L; Walenkamp A; Panzuto F; Pedicini V; Pitoni MG; Siebenhuener A; Mayerhoefer ME; Ruszniewski P; Vullierme MP
J Neuroendocrinol; 2023 Jun; 35(6):e13311. PubMed ID: 37345276
[TBL] [Abstract] [Full Text] [Related]
8. Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study.
Bilici A; Koca S; Karaagac M; Aydin SG; Eraslan E; Kaplan MA; Ocak B; Goksu SS; Paydas S; Akgul F; Derin S; Ergun Y; Yekeduz E; Erol C; Ozyukseler DT; Demiray AG; Karaca M; Guc ZG; Menekse S; Cinkir HY; Gumusay O; Sakin A; Ozkul O; Demir H; Erdem D; Besiroglu M; Unal OU; Acar R; Koral L; Sahin S; Sakalar T; Bahceci A; Ozveren A; Gunaydin UM; Seker MM; Sunar V; Dal P; Artac M; Turhal S
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8243-8253. PubMed ID: 37067546
[TBL] [Abstract] [Full Text] [Related]
9. Organ-specific immune checkpoint inhibitor treatment in lung cancer: a systematic review and meta-analysis.
Yu S; Zhang S; Xu H; Yang G; Xu F; Yang L; Chen D; An G; Wang Y
BMJ Open; 2023 Mar; 13(3):e059457. PubMed ID: 36931679
[TBL] [Abstract] [Full Text] [Related]
10. Successful Right Hepatectomy for Recurrent liver Tumor Originating from an Inferior Vena Cava Leiomyosarcoma: A Follow-Up Case Report.
Nanashima A; Takamori H; Imamura N; Furukawa K; Hiyoshi M; Hamada T; Yano K; Tsuchimochi Y; Kamoto T
Am J Case Rep; 2022 Oct; 23():e938009. PubMed ID: 36301744
[TBL] [Abstract] [Full Text] [Related]
11. Cytomorphology, immunoprofile, and clinicopathologic correlation of metastatic prostatic carcinoma.
Lin X; Shi Q; Yang XJ
Hum Pathol; 2022 Dec; 130():36-46. PubMed ID: 36244466
[TBL] [Abstract] [Full Text] [Related]
12. Pan-cancer gene expression analysis: Identification of deregulated autophagy genes and drugs to target them.
Kondapuram SK; Coumar MS
Gene; 2022 Nov; 844():146821. PubMed ID: 35985410
[TBL] [Abstract] [Full Text] [Related]
13. CT, MRI, and radiomics studies of liver metastasis histopathological growth patterns: an up-to-date review.
Li S; Li Z; Huang X; Zhang P; Deng J; Liu X; Xue C; Zhang W; Zhou J
Abdom Radiol (NY); 2022 Oct; 47(10):3494-3506. PubMed ID: 35895118
[TBL] [Abstract] [Full Text] [Related]
14. A systematic review of the current management approaches in leiomyosarcoma of inferior vena cava-Results from analysis of 118 cases.
Saikia J; Rastogi S; Barwad A; Dhamija E; Pandey R; Bhoriwal S; Deo S; Kumar S
Asian Cardiovasc Thorac Ann; 2022 Mar; 30(3):349-363. PubMed ID: 34672808
[TBL] [Abstract] [Full Text] [Related]
15. De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.
Moosavi SH; Eide PW; Eilertsen IA; Brunsell TH; Berg KCG; Røsok BI; Brudvik KW; Bjørnbeth BA; Guren MG; Nesbakken A; Lothe RA; Sveen A
Genome Med; 2021 Sep; 13(1):143. PubMed ID: 34470666
[TBL] [Abstract] [Full Text] [Related]
16. Interventional Radiology Approaches for liver Metastases from Thyroid cancer: A Case Series and Overview of the Literature.
Nervo A; Ragni A; Retta F; Calandri M; Gazzera C; Gallo M; Piovesan A; Arvat E
J Gastrointest Cancer; 2021 Sep; 52(3):823-832. PubMed ID: 33999355
[TBL] [Abstract] [Full Text] [Related]
17. VASCULAR ANOMALIES IN NEWBORNS: CLINICAL PRESENTATION, COMPLICATIONS, AND PECULIARITIES OF THERAPY.
Benzar IM; Levytskyi AF; Diehtiarova DS; Fedoniuk LY; Stravskyy YS; Merkulova DA; Sas PA
Wiad Lek; 2020; 73(9 cz. 2):1934-1939. PubMed ID: 33148836
[TBL] [Abstract] [Full Text] [Related]
18. Outcomes of Simultaneous Resection of Small Bowel Neuroendocrine Tumors with Synchronous liver Metastases.
Addeo P; Bertin JB; Imperiale A; Averous G; Terrone A; Goichot B; Bachellier P
World J Surg; 2020 Jul; 44(7):2377-2384. PubMed ID: 32179974
[TBL] [Abstract] [Full Text] [Related]
19. The "histological replacement growth pattern" represents aggressive invasive behavior in liver metastasis from pancreatic cancer.
Watanabe K; Mitsunaga S; Kojima M; Suzuki H; Irisawa A; Takahashi H; Sasaki M; Hashimoto Y; Imaoka H; Ohno I; Ikeda M; Akimoto T; Ochiai A
Cancer Med; 2020 May; 9(9):3130-3141. PubMed ID: 32135041
[TBL] [Abstract] [Full Text] [Related]
20. SMARCA4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI/SNF-driven Sinonasal Malignancies.
Agaimy A; Jain D; Uddin N; Rooper LM; Bishop JA
Am J Surg Pathol; 2020 May; 44(5):703-710. PubMed ID: 31934917
[TBL] [Abstract] [Full Text] [Related]
[Next]
